SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SPARC gets Orphan Drug Designation for Phenobarbital

05 Oct 2019 Evaluate

Sun Pharma Advanced Research Company (SPARC) has received Orphan Drug Designation from US Food and Drug Administration (USFDA) for Phenobarbital for the treatment of patients with neonatal seizures. The Orphan Drug Act provides economic incentives to encourage the development of drugs for diseases affecting fewer than 200,000 people in the United States.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

147.00 -0.90 (-0.61%)
20-Apr-2026 09:23 View Price Chart
Peers
Company Name CMP
Syngene Internation. 437.05
Indegene 489.70
CMS Info Systems 317.45
JITF Infralogistics 338.00
Sagility 42.87
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×